LifeScan glucose meter recall
This article was originally published in The Gray Sheet
Users of Johnson & Johnson's OneTouch Ultra, OneTouch FastTake and InDuo need not return the blood glucose monitors despite a Class I recall affecting the devices, FDA clarifies in a FDL-1public message on its website June 13. The monitors permit users to "accidentally change the unit of measure" by dropping the instrument or subjecting it to similar trauma. When J&J/LifeScan became aware of the problem earlier this year, it suspended shipments and notified users. "FDA believes that most patients are capable of understanding and following" the firm's instructions, the agency states, noting that LifeScan now offers alternative devices to curb test misinterpretation. LifeScan reps met with CDRH Director Dan Schultz and Office of In Vitro Diagnostic Devices Evaluation & Safety officials June 3...
You may also be interested in...
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.
Pfizer has revealed launch plans for its Nyvepria pegfilgrastim biosimilar, shortly after receiving formal European Commission approval.